Differential contribution of mitochondria, NADPH oxidases, and glycolysis to region-specific oxidant stress in the anoxic-reoxygenated embryonic heart

The ability of the developing myocardium to tolerate oxidative stress during early gestation is an important issue with regard to possible detrimental consequences for the fetus. In the embryonic heart, antioxidant defences are low, whereas glycolytic flux is high. The pro- and antioxidant mechanism...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of physiology. Heart and circulatory physiology 2011-03, Vol.300 (3), p.H820-H835
Hauptverfasser: Raddatz, Eric, Thomas, Anne-Catherine, Sarre, Alexandre, Benathan, Messod
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page H835
container_issue 3
container_start_page H820
container_title American journal of physiology. Heart and circulatory physiology
container_volume 300
creator Raddatz, Eric
Thomas, Anne-Catherine
Sarre, Alexandre
Benathan, Messod
description The ability of the developing myocardium to tolerate oxidative stress during early gestation is an important issue with regard to possible detrimental consequences for the fetus. In the embryonic heart, antioxidant defences are low, whereas glycolytic flux is high. The pro- and antioxidant mechanisms and their dependency on glucose metabolism remain to be explored. Isolated hearts of 4-day-old chick embryos were exposed to normoxia (30 min), anoxia (30 min), and hyperoxic reoxygenation (60 min). The time course of ROS production in the whole heart and in the atria, ventricle, and outflow tract was established using lucigenin-enhanced chemiluminescence. Cardiac rhythm, conduction, and arrhythmias were determined. The activity of superoxide dismutase, catalase, gutathione reductase, and glutathione peroxidase as well as the content of reduced and oxidized glutathione were measured. The relative contribution of the ROS-generating systems was assessed by inhibition of mitochondrial complexes I and III (rotenone and myxothiazol), NADPH oxidases (diphenylene iodonium and apocynine), and nitric oxide synthases (N-monomethyl-L-arginine and N-iminoethyl-L-ornithine). The effects of glycolysis inhibition (iodoacetate), glucose deprivation, glycogen depletion, and lactate accumulation were also investigated. In untreated hearts, ROS production peaked at 10.8 ± 3.3, 9 ± 0.8, and 4.8 ± 0.4 min (means ± SD; n = 4) of reoxygenation in the atria, ventricle, and outflow tract, respectively, and was associated with arrhythmias. Functional recovery was complete after 30-40 min. At reoxygenation, 1) the respiratory chain and NADPH oxidases were the main sources of ROS in the atria and outflow tract, respectively; 2) glucose deprivation decreased, whereas glycogen depletion increased, oxidative stress; 3) lactate worsened oxidant stress via NADPH oxidase activation; 4) glycolysis blockade enhanced ROS production; 5) no nitrosative stress was detectable; and 6) the glutathione redox cycle appeared to be a major antioxidant system. Thus, the glycolytic pathway plays a predominant role in reoxygenation-induced oxidative stress during early cardiogenesis. The relative contribution of mitochondria and extramitochondrial systems to ROS generation varies from one region to another and throughout reoxygenation.
doi_str_mv 10.1152/ajpheart.00827.2010
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_855200251</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2285018821</sourcerecordid><originalsourceid>FETCH-LOGICAL-c397t-2430a42d138d6929a39cb0235372a5920e8421157982ac80b52dc4d916a21a233</originalsourceid><addsrcrecordid>eNpdkc1u1DAURi0EokPhCZCQxYZNM9jX4yReVi1QpApYwDpy7JsZjxJ7sB2peZE-L-5My6IrS9fn3B99hLznbM25hM96f9ihjnnNWAvNGhhnL8iq_EDFpVAvyYqJWlQ1F_KMvElpzxiTTS1ekzPgXAnZtityf-2GASP67PRITfA5un7OLngaBjq5HMwueBudvqA_Lq9_3dBw56xOmC6o9pZux8WEcUku0RxoxG0xq3RA4wZnTqzPNOWIKVHnad5h8UrdVBHD3bJFrzNailMfl-CLc7zpLXk16DHhu8f3nPz5-uX31U11-_Pb96vL28oI1eQKNoLpDVguWlsrUFoo0zMQUjSgpQKG7abcKhvVgjYt6yVYs7GK1xq4BiHOyadT30MMf2dMuZtcMjiO2mOYU9dKCYyB5IX8-Izchzn6stwRUmWELJA4QSaGlCIO3SG6Scel46x7CK17Cq07htY9hFasD4-t535C-995Skn8A0pXllA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>855297985</pqid></control><display><type>article</type><title>Differential contribution of mitochondria, NADPH oxidases, and glycolysis to region-specific oxidant stress in the anoxic-reoxygenated embryonic heart</title><source>MEDLINE</source><source>American Physiological Society</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Raddatz, Eric ; Thomas, Anne-Catherine ; Sarre, Alexandre ; Benathan, Messod</creator><creatorcontrib>Raddatz, Eric ; Thomas, Anne-Catherine ; Sarre, Alexandre ; Benathan, Messod</creatorcontrib><description>The ability of the developing myocardium to tolerate oxidative stress during early gestation is an important issue with regard to possible detrimental consequences for the fetus. In the embryonic heart, antioxidant defences are low, whereas glycolytic flux is high. The pro- and antioxidant mechanisms and their dependency on glucose metabolism remain to be explored. Isolated hearts of 4-day-old chick embryos were exposed to normoxia (30 min), anoxia (30 min), and hyperoxic reoxygenation (60 min). The time course of ROS production in the whole heart and in the atria, ventricle, and outflow tract was established using lucigenin-enhanced chemiluminescence. Cardiac rhythm, conduction, and arrhythmias were determined. The activity of superoxide dismutase, catalase, gutathione reductase, and glutathione peroxidase as well as the content of reduced and oxidized glutathione were measured. The relative contribution of the ROS-generating systems was assessed by inhibition of mitochondrial complexes I and III (rotenone and myxothiazol), NADPH oxidases (diphenylene iodonium and apocynine), and nitric oxide synthases (N-monomethyl-L-arginine and N-iminoethyl-L-ornithine). The effects of glycolysis inhibition (iodoacetate), glucose deprivation, glycogen depletion, and lactate accumulation were also investigated. In untreated hearts, ROS production peaked at 10.8 ± 3.3, 9 ± 0.8, and 4.8 ± 0.4 min (means ± SD; n = 4) of reoxygenation in the atria, ventricle, and outflow tract, respectively, and was associated with arrhythmias. Functional recovery was complete after 30-40 min. At reoxygenation, 1) the respiratory chain and NADPH oxidases were the main sources of ROS in the atria and outflow tract, respectively; 2) glucose deprivation decreased, whereas glycogen depletion increased, oxidative stress; 3) lactate worsened oxidant stress via NADPH oxidase activation; 4) glycolysis blockade enhanced ROS production; 5) no nitrosative stress was detectable; and 6) the glutathione redox cycle appeared to be a major antioxidant system. Thus, the glycolytic pathway plays a predominant role in reoxygenation-induced oxidative stress during early cardiogenesis. The relative contribution of mitochondria and extramitochondrial systems to ROS generation varies from one region to another and throughout reoxygenation.</description><identifier>ISSN: 0363-6135</identifier><identifier>EISSN: 1522-1539</identifier><identifier>DOI: 10.1152/ajpheart.00827.2010</identifier><identifier>PMID: 21193588</identifier><identifier>CODEN: AJPPDI</identifier><language>eng</language><publisher>United States: American Physiological Society</publisher><subject>Animals ; Antioxidants ; Chick Embryo ; Electron Transport Complex I - antagonists &amp; inhibitors ; Electron Transport Complex I - metabolism ; Electron Transport Complex III - antagonists &amp; inhibitors ; Electron Transport Complex III - metabolism ; Embryos ; Glucose ; Glycogen - metabolism ; Glycolysis - drug effects ; Glycolysis - physiology ; Heart ; Heart - drug effects ; Heart - physiopathology ; Hypoxia - drug therapy ; Hypoxia - metabolism ; Hypoxia - physiopathology ; Iodoacetates - pharmacology ; Lactates - metabolism ; Metabolism ; Methacrylates - pharmacology ; Mitochondria, Heart - drug effects ; Mitochondria, Heart - metabolism ; Mitochondria, Heart - physiology ; Myocardium - metabolism ; NADPH Oxidases - antagonists &amp; inhibitors ; NADPH Oxidases - metabolism ; NADPH Oxidases - physiology ; NG-Nitroarginine Methyl Ester - pharmacology ; Ornithine - analogs &amp; derivatives ; Ornithine - pharmacology ; Oxidative stress ; Oxidative Stress - drug effects ; Oxidative Stress - physiology ; Poultry ; Reactive Oxygen Species - metabolism ; Reperfusion Injury - drug therapy ; Reperfusion Injury - metabolism ; Reperfusion Injury - physiopathology ; Rotenone - pharmacology ; Thiazoles - pharmacology</subject><ispartof>American journal of physiology. Heart and circulatory physiology, 2011-03, Vol.300 (3), p.H820-H835</ispartof><rights>Copyright American Physiological Society Mar 2011</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c397t-2430a42d138d6929a39cb0235372a5920e8421157982ac80b52dc4d916a21a233</citedby><cites>FETCH-LOGICAL-c397t-2430a42d138d6929a39cb0235372a5920e8421157982ac80b52dc4d916a21a233</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,3039,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21193588$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Raddatz, Eric</creatorcontrib><creatorcontrib>Thomas, Anne-Catherine</creatorcontrib><creatorcontrib>Sarre, Alexandre</creatorcontrib><creatorcontrib>Benathan, Messod</creatorcontrib><title>Differential contribution of mitochondria, NADPH oxidases, and glycolysis to region-specific oxidant stress in the anoxic-reoxygenated embryonic heart</title><title>American journal of physiology. Heart and circulatory physiology</title><addtitle>Am J Physiol Heart Circ Physiol</addtitle><description>The ability of the developing myocardium to tolerate oxidative stress during early gestation is an important issue with regard to possible detrimental consequences for the fetus. In the embryonic heart, antioxidant defences are low, whereas glycolytic flux is high. The pro- and antioxidant mechanisms and their dependency on glucose metabolism remain to be explored. Isolated hearts of 4-day-old chick embryos were exposed to normoxia (30 min), anoxia (30 min), and hyperoxic reoxygenation (60 min). The time course of ROS production in the whole heart and in the atria, ventricle, and outflow tract was established using lucigenin-enhanced chemiluminescence. Cardiac rhythm, conduction, and arrhythmias were determined. The activity of superoxide dismutase, catalase, gutathione reductase, and glutathione peroxidase as well as the content of reduced and oxidized glutathione were measured. The relative contribution of the ROS-generating systems was assessed by inhibition of mitochondrial complexes I and III (rotenone and myxothiazol), NADPH oxidases (diphenylene iodonium and apocynine), and nitric oxide synthases (N-monomethyl-L-arginine and N-iminoethyl-L-ornithine). The effects of glycolysis inhibition (iodoacetate), glucose deprivation, glycogen depletion, and lactate accumulation were also investigated. In untreated hearts, ROS production peaked at 10.8 ± 3.3, 9 ± 0.8, and 4.8 ± 0.4 min (means ± SD; n = 4) of reoxygenation in the atria, ventricle, and outflow tract, respectively, and was associated with arrhythmias. Functional recovery was complete after 30-40 min. At reoxygenation, 1) the respiratory chain and NADPH oxidases were the main sources of ROS in the atria and outflow tract, respectively; 2) glucose deprivation decreased, whereas glycogen depletion increased, oxidative stress; 3) lactate worsened oxidant stress via NADPH oxidase activation; 4) glycolysis blockade enhanced ROS production; 5) no nitrosative stress was detectable; and 6) the glutathione redox cycle appeared to be a major antioxidant system. Thus, the glycolytic pathway plays a predominant role in reoxygenation-induced oxidative stress during early cardiogenesis. The relative contribution of mitochondria and extramitochondrial systems to ROS generation varies from one region to another and throughout reoxygenation.</description><subject>Animals</subject><subject>Antioxidants</subject><subject>Chick Embryo</subject><subject>Electron Transport Complex I - antagonists &amp; inhibitors</subject><subject>Electron Transport Complex I - metabolism</subject><subject>Electron Transport Complex III - antagonists &amp; inhibitors</subject><subject>Electron Transport Complex III - metabolism</subject><subject>Embryos</subject><subject>Glucose</subject><subject>Glycogen - metabolism</subject><subject>Glycolysis - drug effects</subject><subject>Glycolysis - physiology</subject><subject>Heart</subject><subject>Heart - drug effects</subject><subject>Heart - physiopathology</subject><subject>Hypoxia - drug therapy</subject><subject>Hypoxia - metabolism</subject><subject>Hypoxia - physiopathology</subject><subject>Iodoacetates - pharmacology</subject><subject>Lactates - metabolism</subject><subject>Metabolism</subject><subject>Methacrylates - pharmacology</subject><subject>Mitochondria, Heart - drug effects</subject><subject>Mitochondria, Heart - metabolism</subject><subject>Mitochondria, Heart - physiology</subject><subject>Myocardium - metabolism</subject><subject>NADPH Oxidases - antagonists &amp; inhibitors</subject><subject>NADPH Oxidases - metabolism</subject><subject>NADPH Oxidases - physiology</subject><subject>NG-Nitroarginine Methyl Ester - pharmacology</subject><subject>Ornithine - analogs &amp; derivatives</subject><subject>Ornithine - pharmacology</subject><subject>Oxidative stress</subject><subject>Oxidative Stress - drug effects</subject><subject>Oxidative Stress - physiology</subject><subject>Poultry</subject><subject>Reactive Oxygen Species - metabolism</subject><subject>Reperfusion Injury - drug therapy</subject><subject>Reperfusion Injury - metabolism</subject><subject>Reperfusion Injury - physiopathology</subject><subject>Rotenone - pharmacology</subject><subject>Thiazoles - pharmacology</subject><issn>0363-6135</issn><issn>1522-1539</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkc1u1DAURi0EokPhCZCQxYZNM9jX4yReVi1QpApYwDpy7JsZjxJ7sB2peZE-L-5My6IrS9fn3B99hLznbM25hM96f9ihjnnNWAvNGhhnL8iq_EDFpVAvyYqJWlQ1F_KMvElpzxiTTS1ekzPgXAnZtityf-2GASP67PRITfA5un7OLngaBjq5HMwueBudvqA_Lq9_3dBw56xOmC6o9pZux8WEcUku0RxoxG0xq3RA4wZnTqzPNOWIKVHnad5h8UrdVBHD3bJFrzNailMfl-CLc7zpLXk16DHhu8f3nPz5-uX31U11-_Pb96vL28oI1eQKNoLpDVguWlsrUFoo0zMQUjSgpQKG7abcKhvVgjYt6yVYs7GK1xq4BiHOyadT30MMf2dMuZtcMjiO2mOYU9dKCYyB5IX8-Izchzn6stwRUmWELJA4QSaGlCIO3SG6Scel46x7CK17Cq07htY9hFasD4-t535C-995Skn8A0pXllA</recordid><startdate>201103</startdate><enddate>201103</enddate><creator>Raddatz, Eric</creator><creator>Thomas, Anne-Catherine</creator><creator>Sarre, Alexandre</creator><creator>Benathan, Messod</creator><general>American Physiological Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7QR</scope><scope>7TS</scope><scope>7U7</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>201103</creationdate><title>Differential contribution of mitochondria, NADPH oxidases, and glycolysis to region-specific oxidant stress in the anoxic-reoxygenated embryonic heart</title><author>Raddatz, Eric ; Thomas, Anne-Catherine ; Sarre, Alexandre ; Benathan, Messod</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c397t-2430a42d138d6929a39cb0235372a5920e8421157982ac80b52dc4d916a21a233</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Animals</topic><topic>Antioxidants</topic><topic>Chick Embryo</topic><topic>Electron Transport Complex I - antagonists &amp; inhibitors</topic><topic>Electron Transport Complex I - metabolism</topic><topic>Electron Transport Complex III - antagonists &amp; inhibitors</topic><topic>Electron Transport Complex III - metabolism</topic><topic>Embryos</topic><topic>Glucose</topic><topic>Glycogen - metabolism</topic><topic>Glycolysis - drug effects</topic><topic>Glycolysis - physiology</topic><topic>Heart</topic><topic>Heart - drug effects</topic><topic>Heart - physiopathology</topic><topic>Hypoxia - drug therapy</topic><topic>Hypoxia - metabolism</topic><topic>Hypoxia - physiopathology</topic><topic>Iodoacetates - pharmacology</topic><topic>Lactates - metabolism</topic><topic>Metabolism</topic><topic>Methacrylates - pharmacology</topic><topic>Mitochondria, Heart - drug effects</topic><topic>Mitochondria, Heart - metabolism</topic><topic>Mitochondria, Heart - physiology</topic><topic>Myocardium - metabolism</topic><topic>NADPH Oxidases - antagonists &amp; inhibitors</topic><topic>NADPH Oxidases - metabolism</topic><topic>NADPH Oxidases - physiology</topic><topic>NG-Nitroarginine Methyl Ester - pharmacology</topic><topic>Ornithine - analogs &amp; derivatives</topic><topic>Ornithine - pharmacology</topic><topic>Oxidative stress</topic><topic>Oxidative Stress - drug effects</topic><topic>Oxidative Stress - physiology</topic><topic>Poultry</topic><topic>Reactive Oxygen Species - metabolism</topic><topic>Reperfusion Injury - drug therapy</topic><topic>Reperfusion Injury - metabolism</topic><topic>Reperfusion Injury - physiopathology</topic><topic>Rotenone - pharmacology</topic><topic>Thiazoles - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Raddatz, Eric</creatorcontrib><creatorcontrib>Thomas, Anne-Catherine</creatorcontrib><creatorcontrib>Sarre, Alexandre</creatorcontrib><creatorcontrib>Benathan, Messod</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Physical Education Index</collection><collection>Toxicology Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of physiology. Heart and circulatory physiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Raddatz, Eric</au><au>Thomas, Anne-Catherine</au><au>Sarre, Alexandre</au><au>Benathan, Messod</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Differential contribution of mitochondria, NADPH oxidases, and glycolysis to region-specific oxidant stress in the anoxic-reoxygenated embryonic heart</atitle><jtitle>American journal of physiology. Heart and circulatory physiology</jtitle><addtitle>Am J Physiol Heart Circ Physiol</addtitle><date>2011-03</date><risdate>2011</risdate><volume>300</volume><issue>3</issue><spage>H820</spage><epage>H835</epage><pages>H820-H835</pages><issn>0363-6135</issn><eissn>1522-1539</eissn><coden>AJPPDI</coden><abstract>The ability of the developing myocardium to tolerate oxidative stress during early gestation is an important issue with regard to possible detrimental consequences for the fetus. In the embryonic heart, antioxidant defences are low, whereas glycolytic flux is high. The pro- and antioxidant mechanisms and their dependency on glucose metabolism remain to be explored. Isolated hearts of 4-day-old chick embryos were exposed to normoxia (30 min), anoxia (30 min), and hyperoxic reoxygenation (60 min). The time course of ROS production in the whole heart and in the atria, ventricle, and outflow tract was established using lucigenin-enhanced chemiluminescence. Cardiac rhythm, conduction, and arrhythmias were determined. The activity of superoxide dismutase, catalase, gutathione reductase, and glutathione peroxidase as well as the content of reduced and oxidized glutathione were measured. The relative contribution of the ROS-generating systems was assessed by inhibition of mitochondrial complexes I and III (rotenone and myxothiazol), NADPH oxidases (diphenylene iodonium and apocynine), and nitric oxide synthases (N-monomethyl-L-arginine and N-iminoethyl-L-ornithine). The effects of glycolysis inhibition (iodoacetate), glucose deprivation, glycogen depletion, and lactate accumulation were also investigated. In untreated hearts, ROS production peaked at 10.8 ± 3.3, 9 ± 0.8, and 4.8 ± 0.4 min (means ± SD; n = 4) of reoxygenation in the atria, ventricle, and outflow tract, respectively, and was associated with arrhythmias. Functional recovery was complete after 30-40 min. At reoxygenation, 1) the respiratory chain and NADPH oxidases were the main sources of ROS in the atria and outflow tract, respectively; 2) glucose deprivation decreased, whereas glycogen depletion increased, oxidative stress; 3) lactate worsened oxidant stress via NADPH oxidase activation; 4) glycolysis blockade enhanced ROS production; 5) no nitrosative stress was detectable; and 6) the glutathione redox cycle appeared to be a major antioxidant system. Thus, the glycolytic pathway plays a predominant role in reoxygenation-induced oxidative stress during early cardiogenesis. The relative contribution of mitochondria and extramitochondrial systems to ROS generation varies from one region to another and throughout reoxygenation.</abstract><cop>United States</cop><pub>American Physiological Society</pub><pmid>21193588</pmid><doi>10.1152/ajpheart.00827.2010</doi></addata></record>
fulltext fulltext
identifier ISSN: 0363-6135
ispartof American journal of physiology. Heart and circulatory physiology, 2011-03, Vol.300 (3), p.H820-H835
issn 0363-6135
1522-1539
language eng
recordid cdi_proquest_miscellaneous_855200251
source MEDLINE; American Physiological Society; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
subjects Animals
Antioxidants
Chick Embryo
Electron Transport Complex I - antagonists & inhibitors
Electron Transport Complex I - metabolism
Electron Transport Complex III - antagonists & inhibitors
Electron Transport Complex III - metabolism
Embryos
Glucose
Glycogen - metabolism
Glycolysis - drug effects
Glycolysis - physiology
Heart
Heart - drug effects
Heart - physiopathology
Hypoxia - drug therapy
Hypoxia - metabolism
Hypoxia - physiopathology
Iodoacetates - pharmacology
Lactates - metabolism
Metabolism
Methacrylates - pharmacology
Mitochondria, Heart - drug effects
Mitochondria, Heart - metabolism
Mitochondria, Heart - physiology
Myocardium - metabolism
NADPH Oxidases - antagonists & inhibitors
NADPH Oxidases - metabolism
NADPH Oxidases - physiology
NG-Nitroarginine Methyl Ester - pharmacology
Ornithine - analogs & derivatives
Ornithine - pharmacology
Oxidative stress
Oxidative Stress - drug effects
Oxidative Stress - physiology
Poultry
Reactive Oxygen Species - metabolism
Reperfusion Injury - drug therapy
Reperfusion Injury - metabolism
Reperfusion Injury - physiopathology
Rotenone - pharmacology
Thiazoles - pharmacology
title Differential contribution of mitochondria, NADPH oxidases, and glycolysis to region-specific oxidant stress in the anoxic-reoxygenated embryonic heart
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T08%3A41%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Differential%20contribution%20of%20mitochondria,%20NADPH%20oxidases,%20and%20glycolysis%20to%20region-specific%20oxidant%20stress%20in%20the%20anoxic-reoxygenated%20embryonic%20heart&rft.jtitle=American%20journal%20of%20physiology.%20Heart%20and%20circulatory%20physiology&rft.au=Raddatz,%20Eric&rft.date=2011-03&rft.volume=300&rft.issue=3&rft.spage=H820&rft.epage=H835&rft.pages=H820-H835&rft.issn=0363-6135&rft.eissn=1522-1539&rft.coden=AJPPDI&rft_id=info:doi/10.1152/ajpheart.00827.2010&rft_dat=%3Cproquest_cross%3E2285018821%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=855297985&rft_id=info:pmid/21193588&rfr_iscdi=true